209 related articles for article (PubMed ID: 20712589)
1. Nanotechnology in cancer therapy: targeting the inhibition of key DNA repair pathways.
Aziz K; Nowsheen S; Georgakilas AG
Curr Mol Med; 2010 Oct; 10(7):626-39. PubMed ID: 20712589
[TBL] [Abstract][Full Text] [Related]
2. DNA repair helicases as targets for anti-cancer therapy.
Gupta R; Brosh RM
Curr Med Chem; 2007; 14(5):503-17. PubMed ID: 17346143
[TBL] [Abstract][Full Text] [Related]
3. Perspective on the pipeline of drugs being developed with modulation of DNA damage as a target.
Plummer R
Clin Cancer Res; 2010 Sep; 16(18):4527-31. PubMed ID: 20823148
[TBL] [Abstract][Full Text] [Related]
4. DNA Damage Signalling and Repair Inhibitors: The Long-Sought-After Achilles' Heel of Cancer.
Velic D; Couturier AM; Ferreira MT; Rodrigue A; Poirier GG; Fleury F; Masson JY
Biomolecules; 2015 Nov; 5(4):3204-59. PubMed ID: 26610585
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers to assess the targeting of DNA repair pathways to augment tumor response to therapy.
Nowsheen S; Whitley AC; Yang ES
Curr Mol Med; 2012 Jul; 12(6):788-803. PubMed ID: 22292444
[TBL] [Abstract][Full Text] [Related]
6. Targeting poly(ADP-ribose) polymerase: a two-armed strategy for cancer therapy.
Plummer ER; Calvert H
Clin Cancer Res; 2007 Nov; 13(21):6252-6. PubMed ID: 17975135
[TBL] [Abstract][Full Text] [Related]
7. Putting poly (ADP-ribose) polymerase and other DNA repair inhibitors into clinical practice.
Helleday T
Curr Opin Oncol; 2013 Nov; 25(6):609-14. PubMed ID: 24097104
[TBL] [Abstract][Full Text] [Related]
8. Targeting BER enzymes in cancer therapy.
Visnes T; Grube M; Hanna BMF; Benitez-Buelga C; Cázares-Körner A; Helleday T
DNA Repair (Amst); 2018 Nov; 71():118-126. PubMed ID: 30228084
[TBL] [Abstract][Full Text] [Related]
9. Targeting DNA damage response kinases in cancer therapy.
Gottifredi V
Mutat Res; 2020; 821():111725. PubMed ID: 33157476
[TBL] [Abstract][Full Text] [Related]
10. [PARP inhibitors: significant progress in cancer therapy].
Dantzer F; Noel G; Schreiber V
Bull Cancer; 2011 Mar; 98(3):277-90. PubMed ID: 21459712
[TBL] [Abstract][Full Text] [Related]
11. Targeted cancer therapies based on the inhibition of DNA strand break repair.
O'Connor MJ; Martin NM; Smith GC
Oncogene; 2007 Dec; 26(56):7816-24. PubMed ID: 18066095
[TBL] [Abstract][Full Text] [Related]
12. [Dbait: An innovative concept to inhibit DNA repair and treat cancer].
Biau J; Devun F; Verrelle P; Dutreix M
Bull Cancer; 2016 Mar; 103(3):227-35. PubMed ID: 26917468
[TBL] [Abstract][Full Text] [Related]
13. Poly(ADP-ribose) polymerase inhibitors in cancer treatment: a clinical perspective.
Sandhu SK; Yap TA; de Bono JS
Eur J Cancer; 2010 Jan; 46(1):9-20. PubMed ID: 19926276
[TBL] [Abstract][Full Text] [Related]
14. Development of PARP inhibitors in oncology.
Rodon J; Iniesta MD; Papadopoulos K
Expert Opin Investig Drugs; 2009 Jan; 18(1):31-43. PubMed ID: 19053880
[TBL] [Abstract][Full Text] [Related]
15. DNA end-processing enzyme polynucleotide kinase as a potential target in the treatment of cancer.
Allinson SL
Future Oncol; 2010 Jun; 6(6):1031-42. PubMed ID: 20528239
[TBL] [Abstract][Full Text] [Related]
16. DNA Damage Repair and the Emerging Role of Poly(ADP-ribose) Polymerase Inhibition in Cancer Therapeutics.
Rabenau K; Hofstatter E
Clin Ther; 2016 Jul; 38(7):1577-88. PubMed ID: 27368114
[TBL] [Abstract][Full Text] [Related]
17. Targeting DNA-PK in cancer.
Damia G
Mutat Res; 2020; 821():111692. PubMed ID: 32172133
[TBL] [Abstract][Full Text] [Related]
18. PARP inhibitors for cancer therapy.
Curtin NJ
Expert Rev Mol Med; 2005 Mar; 7(4):1-20. PubMed ID: 15836799
[TBL] [Abstract][Full Text] [Related]
19. Targeting the DNA damage response in oncology: past, present and future perspectives.
Basu B; Yap TA; Molife LR; de Bono JS
Curr Opin Oncol; 2012 May; 24(3):316-24. PubMed ID: 22476188
[TBL] [Abstract][Full Text] [Related]
20. DNA Double Strand Breaks Repair Inhibitors: Relevance as Potential New Anticancer Therapeutics.
Kopa P; Macieja A; Galita G; Witczak ZJ; Poplawski T
Curr Med Chem; 2019; 26(8):1483-1493. PubMed ID: 29446719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
